Abstract
This research is related to the preparation and initial characterization of gadolinium nanoparticles as a Magnetic Resonance Imaging (MRI) contrast agent. Nanomaterial-based contrast agents aim to improve clearer imaging, longer examination retention times with lower toxicity than gadolinium ion-based contrast agents, and evaluate the potential use of MRI contrast agents for early detection of cancer. Gadolinium nanoparticles were synthesized using polyol method with stabilizer and chemical reaction process at high temperature. The stabilizers used are diethylene glycol (DEG) and triethylene glycol (TEG). The reaction process was carried out at 180°C for 4 hours to obtain gadolinium nanoparticles with uniform size and shape. The results of hydrodynamic and visual measurements using DLS and HRTEM instruments on the gadolinium nanoparticles produced were 50 nm and 18 nm, respectively. The results of the characterization of the crystal structure obtained the X-ray diffraction pattern in the crystal plane (222), which is a typical for the Gd2O3 crystal phase. Characterization of chemical bonds using FTIR showed absorption at 1438-1627 cm−1, 1000-1138 cm−1 and 450-795 cm−1 indicated the presence of Gd-O bond vibrations, while absorption at 1310-1466 cm−1 indicated the presence of Gd-O-Gd bonds. This is evidenced by the similarity with the absorption peak of commercial Gd2O3. The content of free Gd3+ ions found in the synthesized products detected was only about 0.99% of the Gd3+ precursors used.
Highlights
Most hospitals already have Magnetic Resonance Imaging (MRI) to provide neurological, muscoskeletal, cardiovascular and oncological imaging based on pathological changes with abnormal soft tissues in the patient's body [1,2]
Gadolinium (Gd)-based compounds that are widely used for imaging using MRI are complex compounds consisting of one Gd3+ ion that binds to the linear ligand Diethylene Pentaacetic Acid (DTPA) and the cyclic tetraaza ligand cyclo dodecanetetraacetic acid (DOTA) to form Gd-DTPA and Gd-DOTA
With the polyol method and heating, it is expected that the reaction will continue so that gadolinium nanoparticles are obtained in the form of Gd2O3
Summary
Most hospitals already have Magnetic Resonance Imaging (MRI) to provide neurological, muscoskeletal, cardiovascular and oncological imaging based on pathological changes with abnormal soft tissues in the patient's body [1,2]. The compounds Gd-DTPA and Gd-DOTA have low molecular weights, 545 g/mol and 580 g/mol, respectively, requiring high doses to achieve the desired imaging signal effect.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.